Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Opinion: The Great Implant Scandal Or 7.7 Billion Reasons To Celebrate Medical Devices?

Executive Summary

Investigative journalists, tort lawyers, the judicial system and public opinion all provide checks and balances on medical research, industrial innovation and commercial exploitation of health-care technologies. Whether those affected like it or not, these well-intentioned elements of society demand accountability of an industry that has a profound effect on all our lives. The "Implant Files" episode is a reminder for medtech stakeholders across the world that nothing can be taken for granted, says medtech industry and regulatory consultant Trevor Lewis in this guest column for Medtech Insight.

Advertisement

Related Content

Into 2019: Digital Leads US Policy Innovations, But Public Medtech Scrutiny Grows
EU Regulatory Roundup, December 2018: Renewed Focus On Regs While 'Implant Files' Still Grabs Attention
Germany Puts 'Implant Files' In Perspective, As Industry Looks Toward 2019
10 EU-Based Key Medtech Opinion Leaders React To The 'Implant Files'
Nudging Firms To Ditch Older Predicates: A Step In US FDA's Planned 510(k) Reforms
The Implant Files: EU Blamed For Regulatory Inadequacies The World Over While 'Wrath'-Behrendt Fumes
Device Registries In Asia-Pacific/MENA Needed As Focus On Real-World Data Grows
Expert forum rejects European implant registry

Topics

Advertisement
UsernamePublicRestriction

Register

MT124338

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel